Zobrazeno 1 - 10
of 21
pro vyhledávání: '"J C-C Wei"'
Publikováno v:
International Journal of Oral and Maxillofacial Surgery. 51:1482-1487
Juvenile idiopathic arthritis (JIA) is an autoimmune disease that has been proposed to involve the temporomandibular joint (TMJ). The aim of this study was to identify the relationships between JIA, TMJ disorders, and craniofacial deformities. This c
Publikováno v:
Age and Ageing. 52
Background Multimorbidity patterns is associated with future mortality among older adults. However, the addictive effect of disability for distinct multimorbidity patters is unclear. Our aim was to identify the multimorbidity patterns of Taiwanese pe
Publikováno v:
Age and Ageing. 52
Background Multimorbidity has negative impacts on the health outcomes of older adults. Previous research has discovered different patterns of multimorbidity. However, evidence is scarce for associations between multimorbidity patterns and depression,
Autor:
W -M Chu, J C -C Wei
Publikováno v:
QJM : monthly journal of the Association of Physicians. 115(8)
Publikováno v:
QJM : monthly journal of the Association of Physicians.
Publikováno v:
Journal of internal medicine. 291(3)
Publikováno v:
QJM: An International Journal of Medicine. 116:324-325
Autor:
S. Sheikh, M. Scheinberg, J. C. C. Wei, D. Tegzová, W. Stohl, R. Acayaba De Toledo, T. Mucenic, M. R. Abello Banfi, K. Maksimowicz-Mckinnon, C. Abud-Mendoza, S. Navarra, M. García, I. Garcia-De La Torre, A. Liu, A. Roy, P. Wilde, S. Fernandes, J. Harris, D. Roth
Publikováno v:
Annals of the Rheumatic Diseases. 81:637-638
BackgroundBelimumab (BEL) is an approved systemic lupus erythematosus (SLE) treatment. Despite BEL clinical studies demonstrating a favourable benefit–risk profile, varying incidence rates of mortality and adverse events of special interest, includ
Publikováno v:
QJM: An International Journal of Medicine. 116:257-258
Autor:
S. Ramiro, C. Lukas, M. J. Nissen, Y. Schymura, K. Ng, A. Bradley, G. Doridot, S. Liu Leage, A. Chan, J. C. C. Wei
Publikováno v:
Annals of the Rheumatic Diseases. 81:765.2-766
BackgroundIxekizumab (IXE), a monoclonal antibody that selectively targets interleukin IL-17A, has shown efficacy in patients with radiographic axial spondyloarthritis (r-axSpA). Spinal pain, in particular spinal pain at night (SP-N), is a major cont